With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for ...

Artivion also loaned Endospan up to $15 million and secured an option to buy the company within 90 days of the Food and Drug ...

Kweli Thompson will be promoted to head of Medtronic’s neuroscience portfolio, and Peter Menziuso will join BD’s ...

The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional ...

Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of ...

The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several ...

A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the ...

The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies ...

PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...

The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.

The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device. Tandem Diabetes Care ...